One of the main challenges in DHFR research is understanding the mechanisms of resistance to DHFR inhibitors. Resistance can arise from mutations in the DHFR gene, leading to changes in the enzyme's structure that reduce inhibitor binding. Another challenge is the development of selective inhibitors that target the bacterial or cancerous DHFR without affecting the human enzyme, minimizing side effects.
